Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 27 Dec 2023 for POINT Biopharma Global Inc.. Read the official filing
Filing timeline
BuySaleGerald L. Hogue
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gerald L. Hogue: trading record in brief
Gerald L. Hogue discloses dealings in POINT Biopharma Global Inc. to SEC (Form 4). The record holds 3 filings, for trades running from 25 November 2022 to 26 December 2023.
Every open-market trade on record is a purchase: 1 purchase worth €24k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 option exercise.
Most recently, on 27 December 2023, the filings show a transaction in POINT Biopharma Global Inc. The most recent open-market purchase was published on 28 November 2022, 1,420 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gerald L. Hogue
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
21,596 sharesCommon StockSEC:0001104659-23-129771:0
17,936 shares@ US$6.9783.0% of flowCommon StockSEC:0001104659-23-036164:0
3,660 shares@ US$6.81517.0% of flowCommon StockSEC:0001104659-22-122396:0
Canonical exit: 23 Feb 2023 (T+90)
3 of 3 declarations
